Product Description for FGF basic / FGF2
Mouse anti Human FGF basic / FGF2 OTI3D9.
Presentation: Purified
Product is tested for Immunocytochemistry/Immunofluorescence, Paraffin Sections, Western blot / Immunoblot.
Presentation: Purified
Product is tested for Immunocytochemistry/Immunofluorescence, Paraffin Sections, Western blot / Immunoblot.
Properties for FGF basic / FGF2
| Product Category | Primary Antibodies |
|---|---|
| Target Category | |
| Quantity | 0.1 ml |
| Synonyms | BFGF, FGFB, Fibroblast growth factor 2 (basic), HBGF-2, HBGF2, Heparin-binding growth factor 2 |
| Presentation | Purified |
| Reactivity | Hu |
| Applications | ICC/IF, P, WB |
| Clonality | Monoclonal |
| Clone | OTI3D9 |
| Host | Mouse |
| Isotype | IgG2b |
| Shipping to | Europe, USA/Canada |
| PDF datasheet | View Datasheet |
| Manufacturer | OriGene Technologies, Inc. |
Datasheet Extract
| Immunogen |
|
|---|---|
| Isotype control | AM03110PU-N, SM12P |
| Application | WB 1:1000 IHC 1:50 IF 1:100 |
| Background | BFGF is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mR for this gene contains multiple polyadenylation sites, and is altertively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF. |
| Product Citations |
|
| Format |
|
Accessory Products
Proteins and/or Positive Controls
Proteins for FGF basic / FGF2 (31 products)
| Catalog No. | Species | Pres. | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| TP750002 |
FGF basic / FGF2 |
||||||
|
Human |
> 95 % Preparation: . Purity Detail: >95% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli |
0.1 mg /
$411.00
|
|||
| OriGene Technologies, Inc. | |||||||
| TP317426 |
FGF basic / FGF2 |
||||||
|
Human |
> 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
$748.00
|
|||
| OriGene Technologies, Inc. | |||||||
| TP720037 |
FGF basic / FGF2 |
||||||
|
Human |
> 95 % Preparation: . Purity Detail: >95% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli |
10 µg /
$299.00
|
|||
| OriGene Technologies, Inc. | |||||||
| TP723109 |
FGF basic / FGF2 |
||||||
|
Human |
> 95 % Preparation: . Purity Detail: >95% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli | ||||
| OriGene Technologies, Inc. | |||||||
| TP723110 |
FGF basic / FGF2 |
||||||
|
Human |
> 95 % Preparation: . Purity Detail: >95% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli |
50 µg /
$230.00
|
|||
| OriGene Technologies, Inc. | |||||||
| TP723719 |
FGF basic / FGF2 |
||||||
|
Human |
> 98 % Preparation: . Purity Detail: Purity is >98%, as determined by Coomassie stained SDS-PAGE. |
E. coli |
10 µg /
$135.00
|
|||
| OriGene Technologies, Inc. | |||||||
| AR09356PU-L |
FGF basic / FGF2 (recombinant) |
||||||
|
Human | Purified | > 95 % Heparin affinity chromatography | E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR09356PU-N |
FGF basic / FGF2 (recombinant) |
||||||
|
|
Human | Purified | > 95 % Heparin affinity chromatography | E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR09356PU-S |
FGF basic / FGF2 (recombinant) |
||||||
|
|
Human | Purified | > 95 % Heparin affinity chromatography | E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR10036PU-L |
FGF basic / FGF2 |
||||||
|
|
Human | Purified |
>98.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
Insect cells | |||
| OriGene Technologies GmbH | |||||||
| AR10036PU-N |
FGF basic / FGF2 |
||||||
|
|
Human | Purified |
>98.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
Insect cells | |||
| OriGene Technologies GmbH | |||||||
| AR10036PU-S |
FGF basic / FGF2 |
||||||
|
|
Human | Purified |
>98.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
Insect cells | |||
| OriGene Technologies GmbH | |||||||
| AR10039PU-L |
FGF basic / FGF2 (cell culture grade) |
||||||
|
|
Human | Purified |
> 98.0% as determined by both RP-HPLC and SDS-PAGE analysis. Purification Method: Proprietary chromatographic techniques. |
E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR10039PU-N |
FGF basic / FGF2 (cell culture grade) |
||||||
|
|
Human | Purified |
> 98.0% as determined by both RP-HPLC and SDS-PAGE analysis. Purification Method: Proprietary chromatographic techniques. |
E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR10039PU-S |
FGF basic / FGF2 (cell culture grade) |
||||||
|
|
Human | Purified |
> 98.0% as determined by both RP-HPLC and SDS-PAGE analysis. Purification Method: Proprietary chromatographic techniques. |
E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR10041PU-L |
FGF basic / FGF2 (Animal Product Free Grade) |
||||||
|
|
Human | Purified |
> 95% pure as determined by 10% PAGE (coomassie staining). Purification Method: DEAE sepharose, Affinity Chromatography. |
E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR10042PU-L |
FGF basic / FGF2 (Stem Cell Grade) |
||||||
|
|
Human | Purified |
> 98.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR10042PU-N |
FGF basic / FGF2 (Stem Cell Grade) |
||||||
|
|
Human | Purified |
> 98.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR10042PU-S |
FGF basic / FGF2 (Stem Cell Grade) |
||||||
|
|
Human | Purified |
> 98.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR31105PU-N |
FGF basic / FGF2 (164 amino acids) |
||||||
|
|
Human | Purified | > 98 % pure by SDS-PAGE and HPLC analyses | E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR31105PU-S |
FGF basic / FGF2 (146 amino acids) |
||||||
|
|
Human | Purified | > 98 % pure by SDS-PAGE and HPLC analyses | E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR50023PU-N |
FGF basic / FGF2 (143-288) (recombinant) |
||||||
|
Human | Purified | > 95 % by SDS - PAGE | E. coli | |||
| OriGene Technologies GmbH | |||||||
| AR50023PU-S |
FGF basic / FGF2 (143-288) (recombinant) |
||||||
|
|
Human | Purified | > 95 % by SDS - PAGE | E. coli | |||
| OriGene Technologies GmbH | |||||||
| DA3503 |
FGF basic / FGF2 |
||||||
|
Human | Purified | > 98 % by SDS-PAGE and visualised by silver stain | E. coli |
10 µg /
$160.00
|
||
| OriGene Technologies GmbH | |||||||
| DA3503X |
FGF basic / FGF2 |
||||||
|
|
Human | Purified | > 98 % by SDS-PAGE and visualised by silver stain | E. coli |
25 µg /
$180.00
|
||
| OriGene Technologies GmbH | |||||||
| DA3503XC |
FGF basic / FGF2 |
||||||
|
|
Human | Purified | > 98 % by SDS-PAGE and visualised by silver stain | E. coli |
50 µg /
$240.00
|
||
| OriGene Technologies GmbH | |||||||
| PA055 |
FGF basic / FGF2 (154 amino acids) |
||||||
|
|
Human | Purified | > 95 % pure by SDS-PAGE and HPLC analyses | E. coli | |||
| OriGene Technologies GmbH | |||||||
| PA055X |
FGF basic / FGF2 (154 amino acids) |
||||||
|
|
Human | Purified | > 95 % pure by SDS-PAGE and HPLC analyses | E. coli | |||
| OriGene Technologies GmbH | |||||||
| PA1015 |
FGF basic / FGF2 |
||||||
|
|
Human | Purified |
> 95 % Greater than 98.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
Insect cells | |||
| OriGene Technologies GmbH | |||||||
| PA1015X |
FGF basic / FGF2 |
||||||
|
|
Human | Purified |
> 95 % Greater than 98.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
Insect cells | |||
| OriGene Technologies GmbH | |||||||
| PA1015XC |
FGF basic / FGF2 |
||||||
|
|
Human | Purified |
> 95 % Greater than 98.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
Insect cells | |||
| OriGene Technologies GmbH | |||||||
Recommended Secondary Antibodies for FGF basic / FGF2 (11 products)
| Catalog No. | Host | Clone/Iso. | Pres. | React. | Applications | ||
|---|---|---|---|---|---|---|---|
| R1253AP |
Mouse IgG (H+L chain) antibody |
||||||
|
|
Rabbit | AP | C, E, WB | ||||
| OriGene Technologies GmbH | |||||||
| R1253B |
Mouse IgG (H+L chain) antibody |
||||||
|
|
Rabbit | Biotin | C, E, WB | ||||
| OriGene Technologies GmbH | |||||||
| R1253F |
Mouse IgG (H+L chain) antibody |
||||||
|
|
Rabbit | FITC | E, ICC/IF | ||||
| OriGene Technologies GmbH | |||||||
| R1253HRP |
Mouse IgG (H+L chain) antibody |
||||||
|
Rabbit | HRP | C, E, WB | ||||
| OriGene Technologies GmbH | |||||||
| R1253TR |
Mouse IgG (H+L chain) antibody |
||||||
|
|
Rabbit | Texas Red | ICC/IF | ||||
| OriGene Technologies GmbH | |||||||
| R1403R |
Mouse IgG (H+L chain), F(ab)2 Fragment, adsorbed antibody |
||||||
|
|
Rabbit | PE | F | ||||
| OriGene Technologies GmbH | |||||||
| R1405R |
Mouse IgG (H+L chain), F(ab)2 Fragment, adsorbed antibody |
||||||
|
|
Goat | PE | |||||
| OriGene Technologies GmbH | |||||||
| R1455R |
Mouse IgG (H+L chain), F(ab)2 Fragment, adsorbed antibody |
||||||
|
|
Donkey | PE | |||||
| OriGene Technologies GmbH | |||||||
| R1457C2 |
Mouse IgG (H+L chain), adsorbed antibody |
||||||
|
|
Goat | Cy2 | |||||
| OriGene Technologies GmbH | |||||||
| R1457C3 |
Mouse IgG (H+L chain), adsorbed antibody |
||||||
|
|
Goat | Cy3 | |||||
| OriGene Technologies GmbH | |||||||
| R1457C5 |
Mouse IgG (H+L chain), adsorbed antibody |
||||||
|
|
Goat | Cy5 | |||||
| OriGene Technologies GmbH | |||||||
Compare Products
You have no items to compare.
My Cart
You have no items in your shopping cart.
